DIA 48th Annual Meeting
Click here to go to the previous page
Drug Development Strategies and Incorporation of an Established Project Management System
Track : Track 02: Project/Portfolio Management and Strategic Planning
Program Code: 350
Date: Wednesday, June 27, 2012
Time: 1:30 PM to 3:00 PM  EST
CHAIR :
 Marija Ribar, Aptiv Solutions, United States
PRESENTER (S):
 Peter Harpum, Harpum Consulting Ltd., United Kingdom
 Marija Ribar, Aptiv Solutions, United States
Alexander Smith, ADS Pharma Consulting, LLC, United States
Description
This session will look at strategic planning as a foundation upon which a drug development program defines the tasks that need to be completed, when they must be completed, the associate cost, the key personnel and use of established PM system.

Learning Objectives:
Discuss program scope development including all functional areas and key stakeholders to facilitate drug development go/no go decisions
Explain project road map development including costs, timelines, quality, and risk management planning
Describe a strategic planning proposal to incorporate outsourcing models.